http://www.nytimes.com/2011/08/20/health/policy/20drug.html?pagewanted=1&_r=2&hp I think this is great. We need to push for more deregulation and really let corporations do whatever they want. Have everything made overseas with cheap labour, poor factory conditions and cheap ingredients, whatever is necessary to yield higher profits to the shareholders. The sooner we rid the world of our noxious existence, the better.
Too bad nothing in the article you linked to supports your assertions. The one drug specifically named, Doxil is manufactured by a German company in Ohio. J&J receives its Doxil supply from contract manufacturer Ben Venue Laboratories in Bedford, Ohio. Ben Venue is a unit of Boehringer Ingelheim GmbH of Germany. So, a very tiny percent of drugs are in short supply, is that really that big of an issue? Consider: http://www.time.com/time/magazine/article/0,9171,872488,00.html#ixzz1VrAsylnf Or consider: Oh, and by the way, of the top 10 drug companys only 4 of them are in the US, the others are Swiss, German, UK or French. http://en.wikipedia.org/wiki/Pharmaceutical_industry Why haven't you taken your own advice? Arthur
